LogiPharma Europe: Quickfire Questions With Nico Vandaele

Key Takeaways

• Digital twins let pharma test disruption scenarios before they occur
• Traditional safety stock is losing effectiveness against larger, diverse shocks
• Expert knowledge combined with real‑time data drives accurate simulation models
• Energy scarcity and climate events are emerging risks for next five years
• Ambient‑stable formulations reduce reliance on fragile cold‑chain logistics

Pulse Analysis

The pharmaceutical supply chain is moving from a reactive, buffer‑centric approach to a predictive, data‑driven paradigm. Geopolitical tensions, volatile energy markets and climate‑related extremes have turned occasional hiccups into persistent threats, rendering safety stock and excess capacity insufficient. Executives now seek tools that can model the complex interplay of demand spikes, transport bottlenecks and regulatory constraints, allowing them to test multiple futures without jeopardizing patient access.

Digital twins and advanced simulation platforms are the linchpins of this transformation. By embedding both high‑quality, real‑time data—such as demand forecasts, capacity limits and temperature requirements—and deep domain expertise, these models generate consistent, scenario‑based insights. Managers can compare the financial and service impact of actions ranging from rerouting freight to adjusting production schedules, turning uncertainty into quantifiable risk metrics. The result is a more agile decision‑making process that aligns cost efficiency with resilience.

Looking ahead, the next five years will be defined by energy scarcity, climate disruptions and evolving transport policies. Pharma firms are already investing in ambient‑stable formulations and lyophilized powders to mitigate cold‑chain vulnerabilities. Simultaneously, scenario planning must incorporate potential freight restrictions, extreme weather events and regulatory shifts. Companies that embed robust digital twins into their strategic toolkit will not only protect supply continuity but also gain a competitive edge in a market where resilience is becoming a core differentiator.